1. Home
  2. JCTC vs IMRN Comparison

JCTC vs IMRN Comparison

Compare JCTC & IMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JCTC
  • IMRN
  • Stock Information
  • Founded
  • JCTC 1953
  • IMRN 1994
  • Country
  • JCTC United States
  • IMRN Australia
  • Employees
  • JCTC N/A
  • IMRN N/A
  • Industry
  • JCTC
  • IMRN Biotechnology: Pharmaceutical Preparations
  • Sector
  • JCTC
  • IMRN Health Care
  • Exchange
  • JCTC NYSE
  • IMRN Nasdaq
  • Market Cap
  • JCTC 14.7M
  • IMRN 15.0M
  • IPO Year
  • JCTC 1996
  • IMRN N/A
  • Fundamental
  • Price
  • JCTC $4.53
  • IMRN $2.11
  • Analyst Decision
  • JCTC
  • IMRN Strong Buy
  • Analyst Count
  • JCTC 0
  • IMRN 1
  • Target Price
  • JCTC N/A
  • IMRN $5.00
  • AVG Volume (30 Days)
  • JCTC 10.1K
  • IMRN 6.2K
  • Earning Date
  • JCTC 01-14-2025
  • IMRN 12-31-2024
  • Dividend Yield
  • JCTC N/A
  • IMRN N/A
  • EPS Growth
  • JCTC N/A
  • IMRN N/A
  • EPS
  • JCTC 0.21
  • IMRN N/A
  • Revenue
  • JCTC $47,145,176.00
  • IMRN $3,271,194.00
  • Revenue This Year
  • JCTC N/A
  • IMRN N/A
  • Revenue Next Year
  • JCTC N/A
  • IMRN N/A
  • P/E Ratio
  • JCTC $21.89
  • IMRN N/A
  • Revenue Growth
  • JCTC N/A
  • IMRN 171.67
  • 52 Week Low
  • JCTC $3.86
  • IMRN $1.59
  • 52 Week High
  • JCTC $6.35
  • IMRN $5.96
  • Technical
  • Relative Strength Index (RSI)
  • JCTC N/A
  • IMRN 52.87
  • Support Level
  • JCTC N/A
  • IMRN $2.05
  • Resistance Level
  • JCTC N/A
  • IMRN $2.23
  • Average True Range (ATR)
  • JCTC 0.00
  • IMRN 0.16
  • MACD
  • JCTC 0.00
  • IMRN 0.02
  • Stochastic Oscillator
  • JCTC 0.00
  • IMRN 47.06

About JCTC JEWETT-CAMERON TRADING CO

Jewett-Cameron Trading Co Ltd through its subsidiaries engages in the wholesale distribution of a variety of specialty wood products. Its operating segments include, The Industrial wood products segment is engaged in the processing and distribution of industrial wood products. The Pet Fencing and Other segment, which is the key revenue driver, operates as a wholesaler of wood products and a manufacturer and distributor of specialty metal products. The Seed processing and sales segment processes and distributes agricultural seed and Corporate and administrative. The company predominantly operates in United States and also has its presence in Canada, Latin America, Europe and Asia and other regions.

About IMRN Immuron Limited

Immuron Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.

Share on Social Networks: